XTL announces receipt of staff delisting letter from Nasdaq
2026-02-27 16:43:29 ET
More on XTL Biopharmaceuticals
- Seeking Alpha’s Quant Rating on XTL Biopharmaceuticals
- Financial information for XTL Biopharmaceuticals
Read the full article on Seeking Alpha
For further details see:
XTL announces receipt of staff delisting letter from NasdaqNASDAQ: SLE
SLE Trading
40.96% G/L:
$5.85 Last:
41,894,045 Volume:
$6.66 Open:










